2008-2018 Ten years’ service to the pharma and biotech industries

Who we are

Norman E Miller MD, PhD, DSc

DIRECTOR

 

A coauthor of the 1975 hypothesis linking coronary heart disease to low HDL levels, at one time the most cited article ever published in The Lancet. Norman is recognised internationally for his work on lipoproteins and other metabolic risk factors for cardiovascular disease. He is a Fellow of the Royal College of Physicians, Royal College of Pathologists, American College of Physicians, American Heart Association, European Society of Cardiology, Royal Society of Medicine, and Royal Society of Arts. In addition to his many highly cited original articles and reviews, he has edited many books and congress proceedings. He has also organised several succesful symposia, and acted as a consultant to numerous national and international bodies, including the World Health Organisation, American Heart Association, US National Institutes of Health, INSERM, Joint Formulary Committee of the BMA and Pharmaceutical Society of Great Britain, UK Medical Research Council, British Heart Foundation, and UK Ministry of Agriculture, Fisheries and Food. He is a past Waynflete Lecturer of Magdalen College, Oxford, and is currently the Guest Editor of the Frontiers Research Topic on "Apolipoprotein AI and High Density Lipoproteins in the Prevention and Treatment of Disease".

Brief curriculum vitae | Selected publications

     
Registered in England and Wales: number 6501919
VAT registration number: 945 1575 08
Website copyright © Oxford Pharmassist Ltd
web design london : pedalo limited